Introduction
The use of herbal medicine dates back to thousands of years. Although it originated in India and China, it is widely practiced in Africa. Herbal therapy which started as folk medicine in most developed countries is becoming increasingly more popular with patients seeking alternative treatment options. Eisenberg et al., (1998) reported that, in developed countries the number of visits to the alternative medicine practitioners is growing rapidly with the number of visits in US was estimated to be 629 million in 1997; it was believed to have exceeded the number of visits to all primary care physicians. It is a known fact that, a large proportion of African population uses some form of alternative medicine and many do not inform their physician about it. Most patients seek alternative medicine because of lack of basic health facilities, when conventional therapy has failed or they feel the products have no side effects because they are of natural origin. Herbal therapy has also been used extensively in Nigeria. Although more than 80 percent of the people in both the underdeveloped and the developed countries depend on herbal medicines for their medical needs (WHO, 2002) . The major problems with herbal medicines in such countries still remain their poor and sometimes unhealthy presentation.
Being faced with the panorama of resistivity and the attendant side effects associated with orthodox drugs, the focus is now being channeled to naturaceuticals also known as natural products. Bitter leaf botanically called Vernoniaamygdalina, is one of such products. Bitter leaf is a medicinal plant, which grows in the humid tropical secondary forests of Africa. Bitter leaf is among several natural products used by traditional healers in Western Nigeria to treat a number of bacterial infections. The leaves are used as a leafy vegetable for preparing the popular bitter-leaf soup and the juice or extract serves as a tonic drink. It contains 18% protein, 8.5% fiber in a dry matter, and a good composition of macroelements (Egedigwe, 2010) . Moreover, Vernoniaamygdalina has been used in traditional medicine as an antihelminth, an antimalarial, and a laxative herb (Challandet al; 2009). It was observed that an apparently sick wild chimpanzee chewed this plant to extract bitter juice and after a while it seemed to return to its normal activity.
These observations stimulated research on the chemical principals of Vernoniaamygdalina. Acording to Ademolaet al; (February 2011)Several stigmastane-type saponins such as vernoniosides A1, A2, A33, B2, B3, A44, and C5 have been identified in the leaves. It was shown that the A series of these saponins were bitter, mixtures of saponins as well as vernonioside A1 were shown to affect body and liver weights, urine and fecal output, and plasma and liver cholesterol concentrations in mice fed diets amended with these compounds.Avwioroet al; 2005). The antiplasmodial activity of some sesquiterpene and steroidal constituents of Vernoniaamygdalina was tested, and some were proved to be active against Plasmodium falciparum in vitro(Challandet al; 2009). The current search for potential anti oxidative principles to replace suspected tumour-causing synthetic analogues such as BHT7 necessitated this investigation.
Antioxidative principles have been implicated as parts of anticancer formulations and patents8. Although luteoline has been reported to be a strong antioxidant (Bhuyanet al; 2004) , no report has so far been given on the antioxidative potentials of its tannin, alkaloid, anthroquinone, anthracyanosidic and glycosidic derivatives.
The present paper characterizes flavonoids, tannin, alkaloid, anthroquinone, anthracyanosidic and glycosidic derivatives of SAABFAT 5 with Vernoniaamygdalina leaves as one of its active ingredients. This study is therefore designed to determine the clinical activities of SAABFAT 5 with Vernoniaamygdalina as one of its active ingredients, on animals infused with carcinogen.
II. Methodology
EXPERIMENTAL ANIMALS Nine sheep with an average weight of 20 kg each were used for this experiment. The sheep were kept in the animal house of the Ben Amodu farm and research centre, Abuja. They were acclimatized to the environment for 2 weeks. They were fed with commercial feeds pellet and clean water ad-libitum. The cages were cleaned daily SOURCES OF VERNONIAL AMYGDALINA The leaves of Vernoniaamygdalina were harvested fresh from Ben Amodu's farm in kogi state, Nigeria; the required parts of these plants were collected carefully from the farm at the appropriate time. These parts were dried in the sun for one (1) day while it was subjected to seven (7) days air drying under a shade. Care was taken not to allow contamination of any sort. The plant was botanically identified by Dr. U.U Usman of the Botany Department, University of Agriculture Makurdi, Benue State. 150g of the ground dried leaves of Vernoniaamygdalinawas extracted with 1 litre of hot water and another 150g with 1litre of 70% alcohol respectively.
SOURCES OF CARCINOGEN:
Metronidazole is reasonably anticipated to be a human carcinogen based on sufficient evidence of carcinogenicity from studies in experimental animals. The metronidazole was obtained from H.J. Harkins company, Inc. USA.
Hot Water Extraction
A measured quantity (300g) of the ground Vernoniaamygdalinaleaves was dissolved in hot water, mixed by shaking vigorously. This was allowed standing for 1hour, and then filtered to obtain the extract. The filtrate obtained was oven-dried to get rid of the residual water. 18g of the extract was obtained. Using Alcohol as Solvent 300g of ground Vernoniaamygdalinaleaves was dissolved in one liter (1L) of 70% alcohol (ethanol). This was allowed standing for 48hours and then filtered to obtain the extract. The filtrate was oven-dried to get rid of the residual water; 20.24g of the dry extract was obtained.
III.
Preliminary Phytochemical Screening.
The extract of the Vernoniaamygdalina leaves was screened to determine the presence of the following metabolites through the preliminary phytochemical screening. The following active constituents and metabolites were tested for.
Anthracyanosides
Alkaloids
The extract (0.5g) was stirred with 5ml of dilute HCl on a stream bath; 1ml of the filtrate was treated with few drops of Mayers and a second 1ml portion was treated similarly with dragendoff's reagent and finally another lml portion with wagner's reagent. 
Anthraquinone Glycosides
These occurred in both free and bound form (i)
Free Anthraquinone: The extract 0.1g was dissolved with 10ml hot water for aqueous extract and 10ml of alcohol extract, both were put in water bath to steam for 5 minutes, the solution were filtered hot, the filtrate were extracted with chloroform layer was taken off. This layer was washed with 5ml of water and was shaken with 5ml ammonia solution.
(ii)
Bound Anthraquinone A second set of the mixture was prepared with 0.1g of the extract with 10ml of ferric chloride solution and 5ml hydrochloric acid. The sample was hydrolyzed by heating on water bath for 10 minutes, filtered hot and treated as with free anthraquinone.
Test Observation Inference Free anthraquinoneBontrager's test
Presence of red colour in ammonia upper phase.
Free anthraquinone present

Saponins
The ability of saponin to produce frothing in aqueous solution and to haemolyse red blood cells was used as screening. (i) Frothing Test: A little portion of the extract was shaken with water in a test tube.
(ii) Haemolysed Test: Exactly 0.2g Vernoniaamygdalina extract was dissolved in 10ml of warm water and filtered, remaining the filtrate. 2ml of 1.8% sodium chloride (NaCl) solution was put into two test tubes. To one of these 2ml distilled water was added. The concentration of sodium chloride in each test tube was isotonic with blood serum. Five drops of blood were added to each tube and the tubes were inverted gently to mix the contents The administration of the extracts lasted for 21 days. The extracts and the carcinogen were mixed with small quantity of the animals' feed for those in group A before they were given while the carcinogen with the small quantity of the animals' feed were given separately for those in group B. Group A animals were given 200mg/kg/day of the extract and the carcinogen, Group B animals were given 500mg/kg/day of the carcinogen and the animals' feed and Group C animals were given distilled water. The animals were watched closely and vital signs taken for the period the experiment lasted and were euthanatized at the end of the 21 day. Cotton wool was dipped into chloroform and the animals were allowed to inhale the chloroform in a desiccator. They were opened up and the liver and kidney were harvested. The selected pieces of tissue were processed into paraffin wax, sectioned at 5μm and stained by the H and E method, and Perl's Prussian blue method. The stained slides were examined under the microscope and photomicrographs needed were taken. 
IV. Body Weight
The body weight for both the experimental and control animals were taken before and during administration of the extract at interval of 5 days .The mean body weight of each group were calculated and represented on the graph as shown below. Graph illustrating the mean body weight RECTAL TEMPERATURE AND VITAL SIGNS:The rectal temperature taken was to ensure the animals were not sick. This was also done during administration days. The temperature falls in the normal range of 37-39 degree Celsius for rabbits.
FIVE DAYS AFTER THE INITIAL ADMINISTRATION OF THE EXTRACTS AND THE CARCINOGEN:
The group A that was administered the extracts and the carcinogen were moving freely without any sign of sickness while in group B that was administered the carcinogen without the extract were seen with swellings on the eyes, breast and scrotum. There was palpable loss of hairs, nose bleeding and weight loss.
V. Discussion
There was reduction in the body weight of group A(200mg/kg) animals at about day 15 of the administration. This effect of decrease in body weight manifest at around day 5 in group B (500mg/kg),but they started increasing in weight again around day 10.The reduction in weight was as a result of the extract ,because group C(control) does not show any reduction in body weight at all.This is in agreement withEgedigweet al; 2010 in Nigeria, although abino rats were used but the common underlining denominator was the remarking reduction in weight of the abino rat that vernoniaamygdalina was not incorporated in their feed.Statistical analysis done shows that the reduction in the body weight is not significant statistically with none of the group having a p-value less than 0.05. The rectal temperature taken shows that the extract does not cause pyrexia in the experimental animals and along with control group all are having temperature that falls between the normal range of 37-39 degree Celsius. Five days after the administration of the extract and carcinogen respectively, the group A that was administered the extracts and the carcinogen were moving freely without any sign of sickness while in group B that was administered the carcinogen without the extract were seen with swellings on the eyes, breast and scrotum, there was a palpable loss of hairs, nose bleeding and weight loss. This again is in agreement with Amoduet al; 2013 in Nigeria.There was reduction in the body weight of group A(100mg/kg) animals at about day 15 of the administration.This time variation in the weight reduction is central to the dosage used in /kg) show deposition of iron which were in the same quantity with group C (control) and are limited within the hepatocytes but group B (500mg/kg) shows more of iron deposition that extended into the portal region. The kidney section demonstrated using H and E in group Ashows normal histology of the kidney, but in group B renal tubules contain cellular debris, lobular disarray and a lot of pyknotic cells suggestive of acute tubular necrosis which may be due to the effect of the carcinogen while the section from group C animals also appears normal. he liver section from all the groups shows normal hepatocytes, but there was periportal necrosis in one of the animals in group A (100mg/kg).In group B (500mg/kg) canaliculi were dilated, filled with bile and central vein with blood and cellular debris, lobular disarray and a lot of pyknotic cells which may be as a result of the carcinogen.
VI. Conclusion
SAABFAT 5 with Vernoniaamygdalina as it active ingredient had been used in traditional medicine for the treatment of various ailments (Igileet al.,2004) ,it has been used to treat gastrointestinal disorders, haematoma, malaria, inflammation, cancer etc. The methanolic extract of the leaves was investigated on the histology of the liver and kidney. The kidney section demonstrated by Perls Prussian blue reaction shows no iron deposition. The liver sections show more of iron deposition with the carcinogen. There were no significant histological deviation observed in the kidney and liver section of experimental animals compared with control demonstrated by Haematoxylin and Eosin staining technique.
